Therapy Lessens COVID-19 Post-Viral Fatigue 

Translate to Spanish or other 102 languages!

According to a recent study conducted by researchers at Amsterdam UMC, cognitive behavioral therapy is beneficial for individuals with post-viral fatigue following COVID-19. Image for illustration purposes
According to a recent study conducted by researchers at Amsterdam UMC, cognitive behavioral therapy is beneficial for individuals with post-viral fatigue following COVID-19. Image for illustration purposes

Mega Doctor News

- Advertisement -

By Amsterdam UMC

Newswise — According to a recent study conducted by researchers at Amsterdam UMC, cognitive behavioral therapy is beneficial for individuals with post-viral fatigue following COVID-19. The study showed that individuals who underwent behavioral therapy experienced reduced fatigue and concentration problems, as well as improved physical and social functioning. The lead researcher, Professor Hans Knoop, also noted that these improvements were still present six months after treatment. The study has been published in the journal Clinical Infectious Diseases and involved collaboration between Amsterdam UMC, RadboudUMC, and three other hospitals.

After recovering from COVID-19, many patients continue to experience symptoms, commonly known as long-COVID or Post-COVID Syndrome, with severe fatigue being the most common symptom. The ReCOVer study, which was funded by ZonMw, compared patients who received cognitive behavioural therapy with those who received normal care such as supervision by their GP or specialist, physiotherapy, and/or occupational therapy.

- Advertisement -

Tackling fatigue

Cognitive behavioural therapy for patients with post-COVID-19 fatigue aims to help patients manage their symptoms more effectively. This can involve working with patients to improve their sleep patterns and gradually increase their physical activity levels with small, safe steps. According to Professor Hans Knoop, who led the ReCOVer study, the therapy helps patients to become more active and reduce their fatigue levels.

Improving concentration

The study found that cognitive behavioral therapy was effective in reducing fatigue and improving concentration for patients with persistent fatigue after COVID-19. The therapy also helped patients make progress socially and physically. These improvements were still present after six months. The researchers also noted that the therapy was safe and did not result in any worsening of symptoms or new symptoms.

More research required

The researchers want to emphasize that just because behavioral therapy helps alleviate symptoms doesn’t mean that the underlying cause is psychological. They also note that not all patients will benefit from this form of therapy.

It is therefore very important to continue to search for other effective treatments and the physical causes of the post-COVID syndrome.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

STHS Behavioral’s Summer Mental Health Tips for Kids

STHS Behavioral urges families to prioritize emotional well-being by maintaining routines, encouraging social connections and fostering growth beyond the classroom.

New Insight Into the Iron-Retention Strategies of Colorectal Cancer Cells

Mega Doctor News by Michigan Medicine - University of Michigan Newswise — ANN ARBOR, Michigan...

Study: Weight Loss Drugs Cut Risk of Four Cancers by Half or More

Medical News Today The use of glucagon-like peptide-1 (GLP-1) receptor agonistTrusted Source medications continues...

FDA Approves Expanded Use of Kidney Cancer Treatment Rooted in UTSW Discovery

Belzutifan, a first-in-class drug that arose from scientific discoveries at UT Southwestern Medical Center, has been approved by the Food and Drug Administration to treat some patients with earlier stage kidney cancers in combination with an immunotherapy drug. This move marks the latest expansion of belzutifan’s indications after it was originally approved in 2021.
- Advertisement -